The Effect of Sorafenib on Portal Pressure

NCT01714609 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Clinically Significant Portal Hypertension

Interventions

DRUG: Placebo
DRUG: Sorafenib

Sponsor

Yale University

Collaborators

[object Object]